相关实验视频

Updated: Jun 5, 2025

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

针对诱导多能干干细胞的高效化学作用的抗脆弱性治疗衍生出血造干细胞血造干细胞

Daekee Kwon¹, Taewook Lee², Mijung Han²

¹Research Institute, Maru Therapeutics Co., Ltd., Office-706, Hangang-Misa-IS-BIZ Tower, Gyeonggi-do, 12925, South Korea. dk.kwon@marurx.com.

Stem cell reviews and reports

|December 5, 2024

概括

研究人员开发了一种方法,通过诱导多能干细胞 (iPSC) 来产生患者特异性造血干细胞 (HSC). 这种新的方法,使用人参素Rg1和高剂量的busulfan调节,提高了HSC植入效率 in vivo.

科学领域:

干细胞生物学干细胞生物学
血液形成血液形成血液形成
免疫学免疫学免疫学

背景情况:

造血干细胞 (HSC) 对于移植至关重要,但找到匹配的捐赠者是具有挑战性的.
患者特异性干细胞为HSC移植中供体匹配限制提供了解决方案.
目前HSC的来源包括骨髓,带血液和外周血液.

研究的目的:

确定诱导多能干细胞 (iPSC) 有效分化为造血干细胞 (iHSC) 的最佳条件.
为了研究一种假设,即抗脆性治疗可以提高高细胞移植率.
建立一种高效的方法 in vivo 植入iHSC.

主要方法:

诱导多能干细胞 (iPSC) 通过使用抗氧化剂金赛诺化Rg1.1分化为造血干细胞 (iHSC).
差异化的iHSC被静脉注射到Balb/c裸体小鼠中,这些小鼠先接受了不同剂量的busulfan.
通过在移植后2周和8周检测外周血液中人类特异性标记物来评估移植.

主要成果:

与1μM的金色化物Rg1区分的iHSC在体外表现出高的殖民地形成效率.
当iHSC被移植到以125mg/kg或更高的busulfan条件下的小鼠中时,可以实现高效率的移植.
通过人类特异性标志物证实了iHSC在体内成功移植.

结论:

这项研究确定了制造高质量的iHSC和实现高效的in vivo移植的条件.
患者特定的iPSC衍生HSC代表了移植的第四个潜在HSC来源.
随着基因编辑技术的整合,未来的应用可能会扩展到传染病.

关键词:

抗氧化剂是一种抗氧化剂.调整条件调整条件植入方式植入方式血造干细胞移植 (HSCT) 的方法诱导多能干细胞衍生出血造干细胞 (iHSC)

更多相关视频

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

相关概念视频

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.